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AImtract--Using quantitative autoradiography, the cellular localization and characterization of cerebellar 
excitatory amino acid binding sites in normal, Purkinje cell-deficient and granuloprival (granule 
cell-deficient) mouse cerebella were investigated. In the molecular layer of normal mouse cerebellum, 
the quisqualate subtype of excitatory amino acid receptor (assayed by [3H](RS)-a-amino-3- 
hydroxy-5-methylisoxazole-4-propionate, quisqualate-sensitive L-[3H]glutamate, and [3H]6-cyano-7-nitro- 
quinoxaline-2,3-dione binding) predominated. In the granule cell layer of the cerebellum, N-methyl-o- 
aspartate-sensitive L-[3H]glutamate and [3H]glycine binding sites were predominant. 
In the molecular layer of Purkinje cell-deficient mutant mice, [JH](RS)-~,-amino-3-hydroxy-5- 
methylisoxazole-4-propionate binding sites and [3H]6-cyano-7-nitro-quinoxaline-2,3-dione binding were 
reduced to 24% (P < 0.01) and 36% (P < 0.001) of control, respectively, while quisqualate-sensitive 
[3H]glutamate binding sites were reduced to 54% of control (P < 0.01). N-Methyl-I)-aspartate-sensitive 
[3H]glutamate and [3H]glycine binding were unchanged. In the granule cell layer of these mouse cerebella, 
there was no change in excitatory amino acid receptor binding. 
In the molecular layer of granuloprival mouse cerebella, [3H](RS)-a-amino-3-hydroxy-5-methylisoxa. 
zole-4-propionate binding was increased to 205 % of control (P < 0.01), [3H]6-cyano-7-nitro-quinoxaline- 
2,3-dione binding was increased to 136% of control (P < 0.02), and quisqualate-sensitive [3H]glutamate 
binding was increased to 152% of control (P < 0.01). N-Methyl-o-aspartate-sensitive [3H]glutamate and 
[~H]glycine binding were unchanged. In areas of granule cell depletion N-methyl-D-aspartate-sensitive 
[3H]glutamate and [3H]glycine binding were reduced to 68% (P < 0.01) and 59% (P < 0.01) of control, 
respectively. In the granule cell layer, binding to quisqualate receptors was not significantly different from 
binding in controls with any of the ligands tested. 
These results suggest that three different receptor assays: [3H](RS)-~-amino-3-hydroxy-5-methylisoxa- 
zole-4-propionate, quisqualate-sensitive L-[3H]glutamate, and [3H]6-cyano-7-nitro-quinoxaline-2,3-dione 
binding can be used to demonstrate that quisqualate receptor specific binding sites are located on Purkinje 
cell dendrites in the molecular layer of cerebellum, and that these binding sites apparently up-regulate in 
response to granule cell ablation and Purkinje cell deafferentation. 
Glutamate is a major excitatory neurotransmitter in 
the mammalian central nervous system, s,45 Electro- 
physiological evidence indicates that the excitatory 
action of glutamate is mediated by at least three 
subtypes of ion channel-linked ("ionotropic") recep- 
tors named according to the agonists which preferen- 
tially excite them: N-methyl-o-aspartate (NMDA), 
quisqualate, and kainate. 9 In addition, a new 
type of glutamate receptor, a quisqualate-preferring 
"metabotropic" receptor, linked to inositol phospho- 
lipid metabolism has been reported. 42,~ The anatomic 
distribution and pharmacological characterization of  
the glutamate ionotropic receptor subtypes in brain 
sections can be studied. ~4,15,31 L-[3H]Glutamic acid and 
selective incubation conditions have been used to 
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Abbreviations: AMPA, (RS)-a-amino-3-hydroxy-5-methyl- 
isoxazole-4-propionate; CNQX, 6-cyano-7-nitro- 
quinoxaline-2,3-dione; EAA, excitatory amino acid; 
KSCN, potassium thiocyanate; MAM, methyla- 
zoxymethanol; NMDA, N-methyl-o-aspartate. 
measure "quisqualate-sensitive" binding sites in 
brain? These methods, however, may measure both 
the ionotropic and metabotropic quisqualate- 
sensitive receptors. The ionotropic quisqualate recep- 
tor appears to be labeled selectively by [3H](RS)- 
~-amino-3-hydroxy- 5-methylisoxazole-4-propionate 
([3H]AMPA).2°'33'~ The N M D A  receptor can be 
measured with a variety of ligands that bind to the 
neurotransmitter binding site (e.g. glutamate) or to 
modulator sites (e.g. glycine and MK-801). 3,29 
The cerebellar cortex is a convenient region in 
which to study excitatory amino acid (EAA) recep- 
tors because the cerebellar neuronal circuitry is well 
understood33"3° Extensive morphological and neuro- 
chemical evidence supports a neurotransmitter 
function for L-glutamate at afferent mossy fiber ter- 
minals ''l°'t2 and intrinsic granule cell/parallel fiber 
synapses, 22'26"4° and for L-aspartate at afferent climb- 
ing fiber-Purkinje cell synapses. 39,~ Thus, cerebellar 
Purkinje cells receive EAA input from both the 
climbing fibers and the granule cell/parallel fiber 
system, while the granule cells receive such input from 
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the mossy fibers. Selective muta t ions  and  cytotoxic 
drug t rea tments  alter cerebellar circuitry by rendering 
the cerebellum deficient in specific cell types. 24'43 The 
pharmacological  evidence for the multiplicity of E AA 
receptors underscores the impor tance  of  identifying 
the specific EAA  receptor subtypes mediat ing neur- 
onal  t ransmiss ion in the cerebellar cortex. Previous 
work in our  l abora tory  by Olson et al. 36 suggested 
tha t  quisqualate-sensit ive binding sites are located 
principally on dendri tes  of  Purkinje cells and  tha t  
they up-regulate after deafferentat ion.  Advances  in 
EAA research have led to the development  of  several 
new ligands specific for the ionotropic  quisqualate  
receptor.  A M P A  has been described as a potent  and  
selective agonist  of  the ionotropic  quisqualate  recep- 
tor  and the c o m p o u n d  has been radiolabeled.  2°'34 
Studies using [3H]AMPA have been difficult to inter- 
pret  due to the presence of  bo th  high and  low affinity 
binding sites. 19'33 Recently, a relatively selective 
antagonis t ,  6- cyano-  7- n i t ro-quinoxa l ine-2 ,3-d ione  
(CNQX),  of  quisqualate-  or AMPA- induced  re- 
sponses has been developed. In binding studies 
C N Q X  has been shown to b ind with a single affinity 
to bo th  the high and  low affinity A M P A  binding 
sites. 35 The purpose  of  this study was to use normal ,  
granuloprival ,  and  Purkinje cell-deficient mice to 
determine the cellular localization and  regulat ion of  
the ionot ropic  quisqualate-sensit ive b inding sites by 
means  of  quant i ta t ive  receptor au to rad iography  




L-[3H]Glutamate (specific activity 46-53 Ci/mmol) and 
[3H]glycine (19Ci/mmol) were obtained from Amersham 
(Arlington Heights, IL). [3H](RS)-ct-Amino-3-hydroxy-5- 
methylisoxazole-4-propionate ([3H]AMPA; 28-29 Ci/mmol) 
was obtained from New England Nuclear (Boston, MA) 
and CNQX (5.5 Ci/mmol) with a chemical purity > 97% 
and a radiochemical purity _>98% was synthesized by 
Chemsyn Science Laboratories (Lenexa, KA). Non-radio- 
active AMPA, NMDA, and quisqualate were obtained from 
Cambridge Research Biochemicals (Valley Stream, NY). 
Calcium chloride (CaC12) was obtained from Fisher (Fair- 
lawn, N J). All other compounds were purchased from 
Sigma (St Louis, MO). 
Animals 
Homozygous recessive "nervous" mutant mice (nr/nr) 
which are 90% deficient in Purkinje cells were obtained from 
Jackson Laboratories (Bar Harbor, ME). 4~ Neurologically 
normal littermates (n r /+  ) served as controls. Binding ex- 
periments were performed in 42-day-old mice. Granulopri- 
val mice were produced by injecting pups of male CD-I mice 
from Charles River Labs (Wilmington, MA) with methyl- 
azoxymethanol (MAM, 30 mg/kg diluted to a concentration 
of 10 mg/ml in 0.9% NaC1) subcutaneously within 4 h of 
birth. MAM is a nucleic acid alkylating agent which kills 
cells undergoing mitosis at the time of drug distribution. 
When injected on postnatal day 1, MAM causes a depletion 
of granule, stellate, basket, and Golgi cells while sparing 
Purkinje cells in the mouse cerebellum. 6:6'24'25 Binding 
experiments were performed in 42-day-old mice that had 
been treated as pups with MAM. Saline-injected littermates 
were used as controls. 
Tissue preparation 
Forty-two-day-old mice were decapitated and their brains 
were quickly removed. Cerebella were separated from fore- 
brain, mounted on cryotome pedestals with Lipshaw embed- 
ding matrix, and frozen under powdered dry ice. The frozen 
cerebella were cut into 20/~m sections at -20°C on a 
Lipshaw cryostat and thaw mounted onto gelatin-coated 
slides. Sections were stored for less than 24 h at - 20°C. To 
remove endogenous ligands, all sections underwent a pre- 
wash for 30 min at 2°C in either 50 mM Tris-HC1 buffer (pH 
7.20), 50 mM Tris-HCl buffer containing 2.5 mM CaCl 2 
(pH 7.20), 50mM Tris-HC1 buffer containing 2.5mM 
CaC12 and 100mM potassium thiocyanate (KSCN, pH 
7.20), 50mM Tris-acetate buffer (pH 7.40), or 50mM 
Tris-citrate buffer (pH 7.20). Sections were blown dry under 
a stream of room temperature air. The buffer used in the 
prewash was always the same as that used in subsequent 
binding experiments, as described below. 
Autoradiography 
A detailed description of the method for glutamate recep- 
tor autoradiography has been published) 4'34 Briefly, 
"quisqualate-sensitive e-[3H]glutamate binding" was carried 
out at 2°C with 200 nM L-[3H]glutamate in 50 mM Tris-HCl 
containing 2.5mM CaCI 2 and 100#M NMDA, and is 
defined as that binding which is displaced by 2.5/~M 
quisqualate. [3H]AMPA binding assays were carried out 
with 37 nM [3H]AMPA in 50 mM Tris-HCl plus 2.5 mM 
CaC12 and 100 mM KSCN. Non-specific binding was deter- 
mined in the presence of 1 mM unlabeled L-glutamate and 
represented less than 5% of total binding. For both 
[3H]AMPA and quisqualate-sensitive L-[3H]glutamate bind- 
ing assays, sections were incubated for 45 min at 2°C. For 
[3H]CNQX binding, the tissue was incubated for 60 min 
with 64 nM [3H]CNQX at 2°C in 50 mM Tris-HC1. Non- 
specific binding was determined in the presence of 1 mM 
L-glutamate and represented less than 30% of total binding 
of [3H]CNQX. NMDA-sensitive L-[3H]glutamate binding 
was carried out at 2°C with 200 nM e-[3H]glutamate in 
50 mM Tris~cetate buffer containing 2.5/~M quisqualate. 
Non-specific binding was determined in the presence of 
l mM NMDA and represented less than 20% of total 
binding. [3H]Glycine binding was carried out at 2°C with 
100nM [3H]glycine in 50mM Tris~:itrate buffer. Non- 
specific binding was determined in the presence of 1 mM 
unlabeled glycine and represented less than 5% of total 
binding. Saturation studies for [3H]AMPA (2nM-3/~M) 
and quisqualate-sensitive e-[3H]glutamate (3nM-5/~M) 
were carried out in the presence of varying concentrations 
of unlabeled ligands. 
After incubation with tritiated ligands, sections were 
rinsed quickly three times with cold buffer and then rinsed 
with cold 2 .50 (v/v) glutaraldehyde in acetone. The total 
rinse time was less than 10 s. Sections were blown dry with 
warm air. Dried sections were placed in X-ray cassettes with 
appropriate radioactive standards 37 and apposed to Amer- 
sham Hyperfilm. The film was exposed to the tissue sections 
for 14--21 days at 4°C and then developed, fixed, and dried. 
Tissue sections were then postfixed with paraformaldehyde 
and stained with Cresyl Violet. Individual layers of cerebel- 
lum were identified on autoradiographs by comparison with 
the Cresyl Violet-stained sections of the same tissue produc- 
ing the film image. The optical densities of the resultant 
film images were determined using a computer-assisted, 
video-based image analysis system (Imaging Research, St 
Catherines ONT, Canada). Twelve to 18 readings were 
averaged from each area of interest in triplicate sections. 
The radioactivity was determined by a computer-generated 
polynomial regression analysis that compared film densities 
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produced by the tissue sections to those produced by the 
radioactive standards. All data presented were analysed 
densitometrically from autoradiographic images. 
Data analysis 
Binding to the molecular layer and granule layers of 
granuloprival mice was compared to that in saline-treated 
littermates. Similarly, binding in homozygous "nervous" 
mutant mice lacking Purkinje ceils was compared to neuro- 
logically normal littermates. Scatchard analysis and the 
resulting K a and Bm~ values were resolved by the non-linear 




In normal cerebellum the granule cell layer is 
characterized by a very dense collection of cell nuclei. 
The Purkinje cell layer is a monolayer of large 
neurons with pale staining nuclei located between the 
granule cell layer and the molecular layer. The outer 
layer (molecular layer) has relatively few intrinsic 
neurons (basket and stellate cells), and the abundant 
neuropil consists largely of granule cell axons and 
Purkinje cell dendrites (Fig. 1A). In "nervous" mu- 
tant mice (nr/nr), there was a severe depletion of 
Purkinje cells. The granule cell layer had a normal cell 
density, whereas the molecular layer was thinner than 
normal (Fig. IB). In the granuloprival (MAM- 
treated) mice, there was a marked depletion of gran- 
ule cells in a patchy distribution. The damaged 
granule cell layer appeared wider than normal, but 
had a markedly decreased density of granule cell 
nuclei. The molecular layer was slightly narrower 
than in saline-treated controls but had no increase in 
the number of glial cell nuclei. Purkinje cells in these 
animals appeared normal (Fig. 1C). 
Nervous (Purkinje cell-deficient) mice and hetero- 
zygous controls 
In control ( n r / +  ) mice [3H]AMPA binding sites 
(which label ionotropic quisqualate receptors) were 
13 times as numerous in the molecular layer as they 
were in the granule cell layer (total Bm~ x = 36.2 vs 
2.7 pmol/mg protein; Figs 2A and 3A). In the pres- 
ence of 100mM KSCN, saturation studies of 
[3H]AMPA binding produced curvilinear Scatchard 
plots which fit a two-site model better than a one-site 
model (P < 0.001, F-test as compared to a linear 
fit; Fig. 4). The curves in the control mice could 
be resolved into two binding sites with a high 
affinity component Ka = 10 + 4 nM, Bmax = 2.0 + 0.5 
pmol/mg protein and a low affinity component 
Ka = 758 + 157 nM, B~x = 34.2 + 3.4 pmol/mg pro- 
tein. In the molecular layer of "nervous" mutants, 
[3H]AMPA saturation studies again yielded curvi- 
linear Scatchard plots with a high affinity component 
K a = 33 + 14 nM, Bm~x = 2.2 + 1.0 pmol/mg protein, 
and a low affinity component Ka= 570 + 338 nM, 
Bmax = 8.3 + 1.1 pmol/mg protein. Comparison of 
[3H]AMPA binding parameters in control mice and 
"nervous" mice (Table 1) shows a reduction in the 
low affinity B~a~ to 24% of control (P < 0.01) and a 
slight but non-significant decrease in the affinity of 
the high affinity binding site (Fig. 3A, B). In the 
granule cell layer of control mice, [3H]AMPA binding 
produced linear Scatchard plots with Ka= 40 + 3 
nM, Bn~x = 2.7 + 0.1 pmol/mg protein. Similarly, in 
the granule cell layer of Purkinje cell-deficient mice 
[3H]AMPA binding produced linear Scatchard plots 
resolved into a single class of binding sites with 
Ka = 61 + 7 nM, Bm~ = 2.3 + 0.1 pmol/mg protein. 
In control mice quisqualate-sensitive [3H]glutamate 
binding sites were almost two times as numerous in 
the molecular layer as they were in the granule cell 
layer (Bronx = 16.9 vs 10.0 pmol/mg protein; Fig. 2C). 
Scatchard analysis revealed a single binding site 
in the molecular layer with K a = 6 5 8 + 7 6 n M ,  
Bm~x = 16.9 + 9.5 pmol/mg protein. In "nervous" 
mutants, there was a marked loss of quisqualate- 
sensitive [3H]glutamate binding sites in the molecular 
layer where the Purkinje cell dendrites are lo- 
cated. Saturation studies in these mice revealed a 
single class of binding sites with Ka = 842 + 82 nM, 
Bm~ = 9.2 + 0.6 pmol/mg protein. Thus, there was a 
reduction in Bmax to 54% of control (P < 0.01) in the 
molecular layer. Saturation analysis of quisqualate- 
sensitive binding sites in the granule cell layer of 
control mice showed a single class of binding sites 
K a = 1296 + 211 nM, Bm~ = 10.0 + 1.0 pmol/mg pro- 
tein. Quisqualate-sensitive [3H]glutamate binding 
sites were not significantly altered in the granule 
cell layer of "nervous" mice Ka= 799+ 146nM, 
Bm~ x = 7.0 + 1.3 pmol/mg protein (Table 2). 
[3H]CNQX, an ionotropic quisqualate receptor 
antagonist, revealed binding characteristics similar to 
Table 1. Comparison of [3H]AMPA binding parameters in the molecular layer of 
control mice and mice deficient in Purkinje cells ("nervous" mutant mice) 
KH KL Bmaxim Bm~xCL) 
(nM) (pmol/mg protein) 
Control 9.5 _ 3.8 758 ___ 158 2.0 __+ 0.5 34.2 _+ 3.4 
Nervous 32.9 +_ 13.9 570 + 338 2.2 __ 1.0 8.3 _+ 1.1" 
Data represent the mean +_ S.E.M. of three separate experiments (three control and 
three "nervous" mutant mice) performed in Tris-HC1 buffer containing 2.5 mM 
CaCI 2 and I00 mM KSCN. H denotes high affÉnity and L denotes low affinity. 
Data were analysed by the LIGAND program. Two-site fits were significantly 
better than one-site fits in all cases. *P < 0.01 by F-test. 
..... /i 
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Fig. 1. Cresyl Violet-stained sections of control cerebellum (A), Purkinje cell-deficient "nervous" mutant  
cerebellum (B), and cerebellum rendered granuloprival by MAM treatment (C). In control cerebellum the 
granule cell layer (G) is characterized by densely packed granule cell bodies. The Purkinje cells are 
arranged in a monolayer between the granule cell layer and the molecular layer. The molecular layer (M) 
has relatively few intrinsic neurons and abundant  neuropil consisting largely of granule cell axons and 
Purkinje cell dendrites. In Purkinje cell-defident mice there were very few Purkinje cells. The granule cell 
layer appeared normal while the molecular layer was slightly thinner than normal. In granuloprival mice 
there was a marked depletion of granule cells in a patchy distribution. In affected areas, there was a 
decreased density of granule cell bodies. Purkinje cells appeared normal and the molecular layer was 





































































































































































































676 R.L. MAKOWIEC et al. 
Fig. 3. Autoradiographs of [3H]AMPA binding ( A ~ )  and [3H]glycine binding (D-F) in control cerebellum 
(A, D), Purkinje cell-deficient ("nervous" mutant) cerebellum (B, E), and granuloprival (MAM-treated) 
cerebellum (C, F). Although separate sets of controls were used for comparison with the Purkinje 
cell-deficient ("nervous") mice and the granuloprival (MAM-treated) mice, as described under Experimen- 
tal Procedures, only the controls used in the Purkinje cell-deficient ("nervous" mutant) experiment are 
shown. 
[3H]AMPA (Fig. 2A, B). In control mice, when bind- 
ing was done at 90 nM [3H]CNQX there was more 
binding in the molecular layer than in the granule cell 
layer of cerebellum (9.9 vs 1.7 pmol/mg protein) and 
there was a large decrease in binding in the molecular 
layer of"nervous" mice (9.9 vs 3.5 pmol/mg protein). 
[3H]CNQX binding was reduced to 36% of control 
(P<0 .01 )  in the molecular layer of "nervous" 
mutant mice while [3H]CNQX binding was un- 
changed in the granule cell layer of these mice (1.7 vs 
1.5 pmol/mg protein; Table 2). 
In contrast to the quisqualate receptor ligands, 
there was more NMDA-sensitive [3H]glutamate bind- 
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"nervous" mice compared to heterozygote controls 
(Fig. 3D, E). 
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Fig. 4. Saturation analysis of [3H]AMPA binding in the 
molecular layer of control (open circles) vs Purkinje cell- 
deficient (closed circles) mice. These points are representa- 
tive data from individual animals. AMPA binding produced 
curvilinear Scatchard plots which fit a two-site model better 
than a one-site model. There was a large significant 
(P < 0.01) decrease in the number of low affinity binding 
sites in the Purkinje cell deficient "nervous" mutant mouse 
with no change in the high affinity binding sites. See text for 
details. 
than in the molecular layer (0.15 vs 0.02pmol/mg 
protein; Fig. 2D). "Nervous" mutant mice had un- 
changed levels of  N M D A  binding in both the granule 
cell layer and the molecular layer (Table 2). 
In control mice [3H]glycine binding, which labels 
the glycine modulatory site associated with the 
N M D A  receptor complex, 3 paralleled NMDA-  
sensitive binding in that there was more [3H]glycine 
binding in the granule cell layer than in the molecular 
layer (1.2 vs 0.1pmol/mg protein; Fig. 3D). 
[3H]Glycine binding was not significantly changed in 
either the molecular layer or granule cell layer of 
Granuloprival mice and saline-injected controls 
In the molecular layer of granuloprival (MAM- 
treated) mouse cerebella, [3H]AMPA binding 
(measured at a single concentration of 37 nM) was 
increased to 205% of  control (4.1 vs 2.0pmol/mg 
protein; P < 0.01) in regions adjacent to severe gran- 
ule cell depletion (Fig. 3C). [3I-1]AMPA binding was 
unchanged in the granule cell layer of these mice 
(Table 2). Quisqualate-sensitive [3H]glutamate bind- 
ing was increased to 152% of  control (2.6 vs 
1.7 pmol/mg protein; P < 0.01) in the molecular layer 
of these mice. Levels of quisqualate-sensitive 
[3H]glutamate binding were unchanged in the granule 
cell layer of these mice (Table 2). [3H]CNQX binding 
was increased to 136% of control (5.6 vs 4.1 pmol/mg 
protein; P < 0.02) in the molecular layer of  granulo- 
prival mice. [3H]CNQX binding was unchanged in the 
granule cell layer of  these mice. In areas where Cresyl 
Violet staining revealed severe granule cell depletion 
there was a marked reduction in both NMDA- 
sensitive [all]glutamate binding and in [3H]glycine 
binding. NMDA-sensitive [3H]glutamate binding was 
decreased to 68% of control (220 vs 150 fmol/mg 
protein; P <0.01). [3H]Glycine binding was de- 
creased to 59% of control (730 vs 430 fmol/mg 
protein; P <0.01). In contrast, in areas where 
the granule cell layer was not affected by the MAM 
lesion levels of both NMDA-sensitive [3H]glutamate 
binding and [3H]glycine binding were unchanged 
Table 2. Comparison of cerebellar excitatory amino acid binding sites in the molecular layer 
and granule cell layer of control, Purkinje cell-deficient ("nervous") and granuloprival 
(methylazoxymethanol-treated) mice 
Assay 
Purkinje cell-deficient Granuloprival 
(% of control binding + S.E.M.) 
Molecular layer 
[3H]AMPA 24 + I* 205 + 40* 
[3I-I]CNQX 36 _+ 10* 136 + 7** 
Quisqualate-sensitive [3H]glutamate 54 + 9* 149 _+ 16* 
NMDA-sensitive [3H]glutamate 90 + I 94 + 1 
[3H]Glycine 65 _ 26 93 + 6 
Granule cell layer 
[3H]AMPA 78 _+ 6 106 + 14 
[3H]CNQX 87 _+ 30 116 + 29 
Quisqualate-sensitive [3H]glutamate 111 _+ 16 131 _+ 44 
NMDA-sensitive [3H]glutamate 114 + 14 68 + 3* 
[3H]Glycine 98 + 13 59 _ 4* 
Data are presented as percentage of control values + S.E.M. In these experiments separate sets 
of controls were used for comparison with the Purkinje cell-deficient ("nervous") mice and 
the granuloprival (MAM-treated) mice, as described under Experimental Procedures. 
Control values represent 100% in two separate sets of control animals. [3H]AMPA and 
quisqualate-sensitive [3H]glutamate values for Purkinje cell-deficient mice were compared as 
B ~  values from saturation studies. All other percentages reflect changes in specific binding 
at a single concentration of 3H ligand. Levels of significance (**P < 0.02, *P < 0.01 using 
unpaired t-tests) were determined by comparison with appropriate controls. 
NSC 42/3--C 
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from controls. Granuloprival mice had control levels 
of NMDA-sensitive [3H]glutamate binding and 
[3H]glycine binding in the molecular layer of cerebel- 
lum (Table 2). 
DISCUSSION 
Nervous (Purkinje cell-deficient mice) 
Accumulated evidence suggests that L-glutamate is 
the endogenous EAA neurotransmitter at the parallel 
fiber-Purkinje cell synapse. 2'26'27'4s Biochemical data 
reveal that L-glutamate is contained in parallel fibers, 
and that it is released in a calcium-dependent 
fashion. 2s,4° The parallel fiber-Purkinje cell synapse is 
the most numerous synapse in the molecular layer of 
cerebellum) ° Autoradiographic binding studies have 
demonstrated previously that 75% of glutamate 
binding in the molecular layer of normal mice is 
associated with binding to quisqualate-sensitive sites. 4 
The correlation between the abundant parallel 
fiber-Purkinje cell synapses and the comparably 
abundant quisqualate-sensitive binding suggests that 
quisqualate receptors mediate glutamate responses at 
this synapse. 
AMPA is thought to be a potent agonist at the 
quisqualate subclass of glutamate receptors linked to 
a cationic membrane channel. In agreement with 
previous binding studies, in the presence of thio- 
cyanate, [3H]AMPA binding produced curvilinear 
Scatchard plots in the molecular layer of cerebellum 
which could be resolved into two binding sites. 19'33 
In the molecular layer of "nervous" mice lacking 
Purkinje cells there was a large decrease in the low 
affinity [3H]AMPA binding site (Table 1) but no 
change in the high affinity [3H]AMPA binding. In 
contrast, saturation analysis of [3H]AMPA binding in 
the granule cell layer of cerebellum produced linear 
Scatchard plots indicating only high affinity sites and 
these sites did not change in "nervous" mice. Ligand 
binding studies utilizing [3H]AMPA have been com- 
plicated by the presence of high and low affinity 
binding sites and it is not known whether the low 
affinity or high affinity AMPA site revealed in ligand 
binding studies corresponds to the physiologically 
active receptor. In the present study, our Scatchard 
analyses indicate that the low affinity site appears to 
be specific to the Purkinje cells and may thus be the 
relevant receptor there (Fig. 4). Any remaining 
[3H]AMPA binding sites are probably located on the 
10% of Purkinje cells unaffected by the "nervous" 
mutation or on remaining basket, stellate, and Golgi 
cells with which the parallel fibers also synapse. 
Previously, it has been demonstrated that the re- 
gional correlation between levels of quisqualate- 
sensitive [3H]glutamate binding and [3H]AMPA bind- 
ing is excellent, but some differences do exist. 34'35 
Quisqualate-sensitive [3H]glutamate binding appears 
to label both the ionotropic quisqualate receptor and 
the metabotropic quisqualate receptor, whereas the 
more specific ligand AMPA labels only the ionotropic 
quisqualate receptor. 5 AMPA may thus bind to a 
subset of quisqualate-sensitive receptors. Similar to 
published reports and in contrast to [3H]AMPA 
binding, quisqualate-sensitive [3H]glutamate binding 
produced linear Scatchard plots in both the molecu- 
lar layer and the granule cell layer) 6 Competition 
studies indicate that glutamate has similar affinities 
for the ionotropic and metabotropic subtypes of 
quisqualate-sensitive [3H]glutamate binding. The 
large decrease in quisqualate-sensitive [3H]glutamate 
binding in the molecular layer of nervous mutant 
mice suggests that quisqualate receptors are located 
on cerebeUar Purkinje cells, but quisqualate-sensitive 
[3H]glutamate binding does not differentiate between 
ionotropic and metabotropic receptor subtypes. 
Our data appear to suggest that more [3H]AMPA 
binding sites exist in the molecular layer of cerebel- 
lum than quisqualate-sensitive [3H]glutamate binding 
sites. This observation may have resulted from our 
experimental design, since in the quisqualate-sensitive 
[3H]glutamate binding assay we used a single concen- 
tration of quisqualate (2.5 #M) to determine non- 
specific binding for all points in the saturation curve. 
This single concentration was likely to result in an 
underestimate of the proportion of [3H]glutamate 
binding which is quisqualate-sensitive, since the con- 
centration of quisqualate needed to block 95% of the 
high affinity quisqualate sites increases as the concen- 
tration of [3H]glutamate is increased. Thus, we have 
likely underestimated the proportion of quisqualate- 
sensitive [3H]glutamate binding present at high con- 
centrations of [3H]glutamate. The present data are 
therefore inconclusive concerning the hypothesis that 
AMPA binding sites are a subset of all quisqualate- 
sensitive glutamate binding sites. Nevertheless, we 
have recently suggested that there is an AMPA- 
insensitive component of quisqualate-sensitive 
[3H]glutamate binding which appears to label 
metabotropic quisqualate receptors. 5 This AMPA-in- 
sensitive binding component is also decreased in 
nervous (nr/nr) mouse cerebella. 5 It thus seems likely 
that both AMPA-sensitive (ionotropic) and AMPA- 
insensitive (metabotropic) quisqualate receptors are 
located on Purkinje cells. Quisqualate-sensitive 
[3H]glutamate binding sites are also found in the 
granule cell layer of cerebellar cortex. However, these 
sites are unchanged in mutant mice. 
The binding of the potent competitive non-NMDA 
receptor antagonist [3H]CNQX ~8 correlates highly 
with the properties and distribution of [3H]AMPA 
binding (Fig. 2A, B). 2t'35 Analysis of [3H]CNQX bind- 
ing in Purkinje ceil-deficient mice was decreased to 
almost the same level as [3H]AMPA binding in the 
molecular layer of cerebellum but was not altered in 
the granule cell layer. The larger decrease in the 
binding of both ionotropic specific ligands (AMPA 
and C N Q X ) t h a n  in quisqualate-sensitive [3n]- 
glutamate binding (Table 2) may indicate that a 
larger percentage of cerebellar ionotropic receptors 
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reside on Purkinje cells than metabotropic receptors. 
As reported previously, in the cerebellar cortex 
NMDA-sensitive [3H]glutamate binding is more 
abundant in the granule cell layer than in the molecu- 
lar layer (Fig. 2D). ~4,36 These binding sites in the 
granule cell layer may be located on the granule cells 
themselves as they are the target of excitatory input 
from mossy fibers, and based on immunocytochemi- 
cal data, the mossy fibers may be giutamatergic.l In 
Purkinje cell-deficient mutant mice, NMDA binding 
sites were unchanged in the molecular layer of  cer- 
ebellar cortex. This evidence suggests that few, if any, 
NMDA binding sites are located on Purkinje cell 
dendrites and further strengthens the supposition that 
quisqualate receptors mediate excitatory trans- 
mission at the parallel fiber-Purkinje cell synapse. It 
is likely that binding to NMDA receptors in the 
molecular layer is localized to stellate cells and poss- 
ibly to basket and Golgi cells: this is in agreement 
with electrophysiological studies in which NMDA 
has prominent effects on inhibitory interneurons 
when applied iontophoretically. 7,3s 
In agreement with this, [3H]glycine binding, which 
presumably binds to the glycine site associated with 
the NMDA receptor complex, mimics the NMDA 
binding results (Fig. 3A). These binding data, in 
conjunction with electrophysiological and neurotoxi- 
city studies, further suggest that the NMDA receptor 
complex is not localized to Purkinje cel ls .  7'11"13'17 
Granuloprival mice 
It has been shown previously in both homogenate 
and autoradiographic studies that [3H]glutamate 
binding increases following neonatal MAM treat- 
ment in mouse cerebella. 36,43 We have also found that 
when Purkinje cells are deafferentated by granule cell 
damage in MAM-treated mice there is an increase in 
quisqualate-specific [3H]glutamate binding in areas of 
the molecular layer adjacent to the regions of greatest 
granule cell ablation. Although we cannot rule out 
that the increase in receptor density is merely an effect 
of  an enriched concentration of  Purkinje cell den- 
drites in a parallel fiber-deficient area, it is notewor- 
thy that Slevin et al. found a 70% increase in the 
binding of [3H]glutamate (under non-selective bind- 
ing conditions) even when accounting for changes in 
loss of cerebellar m a s s .  43'47 By utilizing the anatomical 
resolution possible with receptor autoradiography 
and ligands selective for glutamate receptor subtypes 
we found the increase in glutamate receptors to be 
localized to the molecular layer of cerebellum and to 
be of the quisqualate type. Due to the deficiency of 
granule cell glutamatergic input and the preservation 
of  normal postsynaptic dendritic spines on the Purk- 
inje cells of  granuloprival mice, it may be postulated 
that the increase in quisqualate receptor-specific 
ligand binding reflects an actual up-regulation of 
receptors on the surviving neurons. The up-regu- 
lation hypothesis seems likely to be due to the 
specificity of  the binding sites being increased. Only 
assays of the quisqualate receptor-specific ligands 
(quisqualate-sensitive [3H]glutamate, [aH]AMPA, 
and [3H]CNQX) showed increases in areas of  the 
molecular layer directly adjacent to severe granule 
cell ablation. If  the increase in glutamate binding sites 
was due to a concentrating effect then all glutamate 
receptor binding sites would be expected to increase. 
This was not the case since the two NMDA-specific 
ligands (NMDA-sensitive [3H]glutamate and 
[aH]glycine) revealed no significant changes in bind- 
ing in either layer of the cerebellar cortex of granulo- 
prival mice. Furthermore, previous reports indicated 
that [3H]kainate binding sites are unchanged by this 
treatment. 36 
While the trend for the quisqualate receptor- 
specific ligands in the granuloprival mouse cerebel- 
lum is consistent, considerable variation in the degree 
of increased binding exists. There are both methodo- 
logical and physiological explanations which could 
explain this difference. Methodologically, the data on 
the granuloprival cerebellum were obtained at single 
ligand concentrations and thus do not differentiate a 
relative change in receptor number or affinity. How- 
ever, both Olson et al. 36 and Slevin et al. 43 have 
reported saturation studies in MAM-treated mouse 
cerebella that suggest only a change in receptor 
number and not in the affinity of glutamate binding 
sites. More likely, the discrepancy reflects the com- 
plexity of quisqualate receptors themselves. Not only 
is it possible that two classes of quisqualate receptors 
exist (ionotropic and metabotropic), it has been 
proposed that the ionotropic quisqualate receptor 
itself has dual affinity statesJ 9 
We have provided evidence that three receptor 
ligands can be used to label quisqualate-specific EAA 
binding sites: quisqualate-sensitive [3H]glutamate 
binding, [3H]AMPA binding, and [3H]CNQX bind- 
ing. Although the changes observed with the different 
ligands were not identical, the direction of the 
changes correlated well in the Purkinje cell-deficient 
("nervous" mutants) and granuloprival (MAM- 
treated) mouse cerebella studied here. Thus, we have 
provided new and corroborative evidence that 
suggests that qulsqualate receptors, measured with 
three different ligands, localize to the dendrites of 
cerebellar Purkinje cells and can up-regulate in re- 
sponse to deafferentation. Also, we have demon- 
strated that both NMDA and glycine receptor 
populations are located predominantly in the granule 
cell layer and that they are probably not present on 
Purkinje cells in the molecular layer in adult mice. 
Finally, the present data suggest that the low affinity 
AMPA binding site may be the component of AMPA 
binding which corresponds to the physiologically 
relevant receptor. 
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